AUSTRALIAN STOCKS FALL: Here's what you need to know

Australia’s Shane Watson looks up after falling while batting during the 2015 ICC Cricket World Cup match between Australia and New Zealand. Mark Kolbe/Getty Images

The Australian market followed global markets down to dip for the second session in a row.

Here’s the scoreboard:

  • S&P ASX 200: 5,901.60 -32.30 (-0.54%)
  • All Ordinaries: 5,871.50 -31.37 (-0.53%)
  • AUD/USD: 0.7814 -0.0002 (-0.03%)

Wall Street was weaker overnight with the S&P 500 closing down -0.5%.

On the local market, 6 out of 10 sectors ended weaker. The major banks and miners all closed down, led by the Commonwealth Bank which lost 0.87% to $91.12. Rio Tinto, trading ex-dividend, was 3.6% down to close at $62.45.

The top stories on Wednesday:

1. An unexplained sharp rise. ASIC is investigating suspicious trading in the Australian dollar just before the RBA’s interest rate announcement

2. Share frenzy. Biotech Novogen announces one of its drugs is found to work against brain cancer. The shares jump by half and closed up more than 38% to $0.18.

3. Flying high. Macquarie Group announced a huge expansion of its aircraft leasing business, buying a portfolio of 90 jets in a deal worth more than $5 billion. Macquarie’s shares were down more than 2% to $73.52.

4. GDP is 2.5%. It’s slightly below the 0.6%/0.7% range expected by the market. While it’s not a terrible result, it does reflect continuing weakness in the economy.

NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at